A gonadotropin-releasing hormone agonist versus a low-dose oral contraceptive for pelvic pain associated with endometriosis.
about
Endometriosis still a challengeGonadotropin releasing hormone agonists: Expanding vistasLong-term follow-up of a controlled trial of laser laparoscopy for pelvic painRole of estrogen receptor-β in endometriosisOptimal management of chronic cyclical pelvic pain: an evidence-based and pragmatic approachExtracts from the "clinical evidence". Endometriosis.Post-laparoscopic oral contraceptive combined with Chinese herbal mixture in treatment of infertility and pain associated with minimal or mild endometriosis: a randomized controlled trial.Comparison study on effectiveness of pentoxifyllin with LD to prevent recurrent endometriosisEndometriosis for the colorectal surgeon.Progesterone action in endometrial cancer, endometriosis, uterine fibroids, and breast cancer.Diagnosis and management of dysmenorrhoea.Randomized trial of leuprolide versus continuous oral contraceptives in the treatment of endometriosis-associated pelvic painEstrogen receptor-beta, estrogen receptor-alpha, and progesterone resistance in endometriosis.Endometriosis: alternative methods of medical treatment.National German Guideline (S2k): Guideline for the Diagnosis and Treatment of Endometriosis: Long Version - AWMF Registry No. 015-045Endometriosis-associated nerve fibers and painManaging endometriosis-associated infertility.Pain and endometriosis: Etiology, impact, and therapeutics.Increased AKT or MEK1/2 activity influences progesterone receptor levels and localization in endometriosis.Interdisciplinary S2k Guidelines for the Diagnosis and Treatment of Endometriosis: Short Version - AWMF Registry No. 015-045, August 2013.Effect of octreotide on endometriosis in acromegaly: Case report with review of literatureActivated AKT pathway promotes establishment of endometriosis.Cutting SRC-1 down to size in endometriosis
P2860
Q26827653-59E3F7E5-F4D3-40F0-BA70-B400AB4173B1Q28251457-39933ED3-F3CF-4546-90A2-4E92C508F6FEQ28366425-0AAEAE34-EF10-4060-839C-DC6A1894CBD9Q33667641-01260F00-AE32-4139-B8A2-CF03A64A8F1BQ33769215-573E048A-D54F-4099-8CB8-8231C972F169Q33817668-1642307F-AD87-4558-80E0-4BB848A611A3Q33865261-71CEB450-25D9-474E-929A-8593929F1D78Q34196646-441EE5B1-EAC3-4797-9671-F0D2BBA1B7C5Q34257207-13750FB8-3DF2-43B7-A137-BA9895860ECAQ34321877-DBB86F96-8785-44AC-94A4-4C5F23937AEEQ34601347-2FE128C3-DDAE-4564-B7D6-F788D8ED5748Q34742924-1A981F67-4F2C-4A45-96DA-64498738FB7CQ34775795-37D24EF1-0D9A-4994-91B9-4602AE3ABC44Q35668144-197223C8-3E4B-4BE7-9B3D-F5298E942DFEQ35751129-854B716A-5144-4340-9C24-A07CF723C15DQ36010672-29962AD1-D0EA-44C1-A275-5ADDFF8EB1B6Q36059955-80A3E0E4-D4D1-480D-81B2-EFCBF27585B4Q36880529-936E95F5-2036-471E-A2F4-034D139949E1Q37361813-8D39C7E4-6072-4B10-A468-E2D972DDCB42Q37683908-6A77610A-2561-48BE-B88C-D964A501DCA9Q37703725-BA903499-8A4A-4507-BD73-CB7D0264BC02Q37709202-0E00B27A-74B0-4911-AC38-41851C5C74F9Q42716405-3D8E8637-E749-452A-B415-D9B36557AAEB
P2860
A gonadotropin-releasing hormone agonist versus a low-dose oral contraceptive for pelvic pain associated with endometriosis.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
A gonadotropin-releasing hormo ...... associated with endometriosis.
@en
A gonadotropin-releasing hormo ...... associated with endometriosis.
@nl
type
label
A gonadotropin-releasing hormo ...... associated with endometriosis.
@en
A gonadotropin-releasing hormo ...... associated with endometriosis.
@nl
prefLabel
A gonadotropin-releasing hormo ...... associated with endometriosis.
@en
A gonadotropin-releasing hormo ...... associated with endometriosis.
@nl
P2093
P1476
A gonadotropin-releasing hormo ...... associated with endometriosis
@en
P2093
L Trespidi
M Marchini
P G Crosignani
P Vercellini
P356
10.1016/S0015-0282(16)56039-7
P407
P577
1993-07-01T00:00:00Z